Skip to search formSkip to main contentSkip to account menu

VePesid-Ifosfamide-Platinol Regimen

Known as: VP16-Ifosfamide-Platinol Regimen, Etoposide-Ifosfamide-Cisplatin Regimen, VIP 
A regimen consisting of etoposide, ifosfamide and cisplatin used for the treatment of advanced-stage germ cell gonadal cancers.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
PURPOSE To evaluate the feasibility and the toxicity of sequential, dose-intensified chemotherapy combined with paclitaxel plus… 
Review
2004
Review
2004
Despite the fact that Ewing sarcoma family of tumors (ET) is chemosensitive, long-term survival is extremely rare for patients… 
2000
2000
Abstract: VIP and PACAP, two structurally related neuropeptides produced within the lymphoid microenvironment, modulate several… 
1999
1999
The aim of the study was to evaluate peripheral blood progenitor cell mobilization by disease-specific chemotherapy in heavily… 
1995
1995
PURPOSE Ifosfamide-containing therapy with cisplatin plus either etoposide (VIP) or vinblastine (VeIP) can cure of patients with… 
1994
1994
PURPOSE To evaluate the efficacy and toxicity of ifosfamide in combination with cisplatin and vinblastine in non-operable non… 
1992
1992
From December 1987 through April 1989, 40 patients with extensive‐stage small cell carcinoma of the lung were enrolled in a…